Skip to content

Effect of a new nutritional preparation (TY007) on nutritional status of patients with diabetes in convalescence

Effect of a new nutritional preparation (TY007) on nutritional status of patients with diabetes in convalescence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099137
Enrollment
Unknown
Registered
2025-03-19
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Intervention group:Tube feeding of new common full nutrition preparations
Control group:Tube feeding enteral nutrition preparation for diabetes

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age 18 and above, gender not limited; 2. A gastric tube has been placed; 3. Patients with a serum albumin level of 30-40 g/L and an NRS2002 score greater than 3, indicating medical nutritional needs; 4. The condition is relatively stable, and the expected life expectancy is not less than one month; 5. In patients with diagnosed diabetes or impaired glucose tolerance, the amount of insulin or glucose control drugs was relatively stable during the intervention period, and the postprandial blood glucose was <= 13.9 mmol/L; 6. Triglycerides<4.5mmol/L; 7. Not using parenteral nutrition support; 8. Can tolerate enteral nutrition.

Exclusion criteria

Exclusion criteria: 1. Those who are using other nutritional preparations that may affect the efficacy of the trial or who are allergic to the ingredients of the products; 2. Participating in other interventional clinical trials (including drugs, nutritional preparations, medical devices, etc.) within 4 weeks before screening; 3. Complicated with severe diseases in the past 3 months, such as severe infection and surgical operation; 4. Liver and kidney dysfunction (transaminase > 2 times the upper limit of normal reference range, CKDG3a or above); 5. Patients who were intolerant to or allergic to nutritional preparations in the past.

Design outcomes

Primary

MeasureTime frame
Calf circumference;Weight;

Countries

China

Contacts

Public ContactWen Hu

West China Hospital of Sichuan University

wendy_nutrition@163.com+86 189 8060 1164

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026